Skip to content

Neurobiological Similarities of Tinnitus and PTSD

An Evaluation of Neurobiological Similarities of Tinnitus and Posttraumatic Stress Disorder

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05981391
Enrollment
64
Registered
2023-08-08
Start date
2021-02-04
Completion date
2024-11-01
Last updated
2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posttraumatic Stress Disorder, Tinnitus

Keywords

resting-state fMRI, PTSD, tinnitus, military, veterans

Brief summary

Psychiatric distress caused by PTSD may increase attention toward tinnitus, as well as perceived loudness and discomfort. It is important to understand how tinnitus-related distress and PTSD negatively interact together, in order to develop more effective therapeutic approaches. Understanding symptoms and neurobiological mechanisms using functional magnetic resonance imaging (fMRI), can lead to the necessary knowledge to develop effective interventions for individuals who suffer from both conditions.

Detailed description

Tinnitus and posttraumatic stress disorder (PTSD) are two of the most common service-connected disabilities for active-duty Service Members and Veterans. Tinnitus and PTSD are highly co-morbid, yet distinct disorders. Tinnitus is an auditory disorder in which an illusory auditory percept is experienced, usually as ringing, buzzing, or whooshing sounds, despite no external objective noise source. On the other hand, PTSD is a trauma-related disorder, and is identified by intrusions of the traumatic event, avoidance of reminders, negative alterations in cognition and mood, and hypervigilance or hyperarousal. Similarities between tinnitus and PTSD have been documented among Cambodian refugees, as well as among U.S. Veteran samples. Moreover, the latest neuroimaging data from a recent clinical trial indicated that the auditory-vigilance network was the most dysregulated among active-duty service members with PTSD, compared to combat controls and civilian controls. Due to similar symptoms between tinnitus-related distress and PTSD, and similar dysregulated resting-state brain networks, it remains important to more fully understand how these two distinct disorders may be related. This study will be the first to prospectively examine the overt emotional, behavioral, and cognitive symptoms related to tinnitus-related distress and PTSD, and the overlapping functional connectivity between tinnitus and PTSD. Investigators will examine the overlapping symptoms and neurobiological mechanisms by conducting audiometric and psychological assessments and resting-state functional magnetic resonance imaging (fMRI) among 120 participants (30 with tinnitus and PTSD, 30 with only PTSD, 30 with only tinnitus, and 30 healthy controls). Participants will be recruited from the Frank Tejeda PTSD Clinic and the Audiology Clinic within the South Texas VA Health Care System, and the Hearing Center of Excellence at Lackland Air Force Base. Canonical correlations will be conducted to examine the symptom overlap between tinnitus and PTSD (Aim 1). Investigators aim to neurobiologically characterize tinnitus and PTSD, both separately and conjointly, by conducting fMRI (Aim 2). Investigators also aim to apply modeling to psychometric and neurofunctional data to identify specific regions of the auditory-vigilance network associated with distress related to tinnitus and PTSD. Understanding the shared cognitive, emotional, and behavioral symptoms and neurobiology associated with tinnitus and PTSD will help clinicians and researchers fully understand tinnitus and PTSD independently and conjointly. Results will lead to the identification of neurobiological markers for tinnitus and PTSD, identification of a different phenotype for individuals with both conditions, and development of behavioral and neuro-modulatory therapies that can reduce distress and impairment.

Interventions

We will acquire BOLD fMRI images in an unstimulated state using an extended time-series (300 whole-brain volumes over \ 60-75 min). These data are a main outcome. Data will be processed on an ongoing basis to ensure integrity, and includes controlling for white matter, cerebral spinal fluid, and movement.

DIAGNOSTIC_TESTClinician Administered PTSD Scale for the DSM-5 (CAPS-5)

The CAPS-5 is a semi-structured interview, conducted by an independent evaluator, that measures DSM-5 symptoms of PTSD. Presence of at least one intrusion symptom, one avoidance symptom, two cognition and mood symptoms, and two arousal symptoms for 1 month or more are required to reach the diagnostic threshold.

DIAGNOSTIC_TESTTympanometry

Tympanometry will be conducted to assess ear canal volume (cm cubed), maximum pressure (daPa) peak compliance (ml), and type (A, AD, AS, B, B-High, C) for each ear) at 226-Hz admittance.

DIAGNOSTIC_TESTTinnitus Assessment

Tinnitus acoustic assessment (for tinnitus participants only): Tinnitus ear (left, right, bilateral), pitch matched frequency (Hz) and loudness matched intensity (dB) will be conducted. When available, the tinnitus acoustic assessment only will be repeated at the RII, on the same day and prior to the fMRI scan, to demonstrate reproducibility of results.

DIAGNOSTIC_TESTOtoscopy

Otoscopy is a clinical procedure used to examine structures of the ear, particularly the external auditory canal, tympanic membrane, and middle ear

DIAGNOSTIC_TESTPure tone air and bone-conduction

Pure tone air- and bone-conduction threshold will be conducted to evaluate audiometry and masking levels in both ears, from 250 Hz. To 16000 Hz.

DIAGNOSTIC_TESTSpeech testing

Speech testing will be conducted in both ears, which will include speech reception threshold, speech reception threshold masking level, word recognition presentation level, and word recognition masking level.

DIAGNOSTIC_TESTLoudness Discomfort

Loudness discomfort levels will be tested in both right and left ears, from 500Hz to 4000Hz and speech reception threshold.

DIAGNOSTIC_TESTQuick Speech in Noise Test

Quick Speech in Noise Test (QuickSIN) is a quick method for clinicians to quantify a patient's ability to hear in noise (1 minute).

DIAGNOSTIC_TESTDistortion-Product Otoacoustic Emissions (DPOAE)

Distortion-Product Otoacoustic Emissions (DPOAE) is an automated evaluation of cochlear function. A sensitive microphone is placed in the ear canal via a probe assembly with a disposable ear-tip attached to perform and record the measurements. DPOAEs will be elicited at multiple frequencies in both ears (10 min).

Sponsors

Hearing Center of Excellence
CollaboratorFED
National Institute of Mental Health (NIMH)
CollaboratorNIH
The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and female DEERS eligible veterans and active duty service members, ages 18 and above * preferred language is English and able to read and speak English at a 6th grade level * those with PTSD (T&P; PO) must meet full criteria for PTSD diagnosis based on the DSM-5 and assessed by an independent evaluator using the CAPS-5 * those with chronic, constant tinnitus (T&P, TO) will be identified by self-report and confirmed with the audiometric assessment.

Exclusion criteria

* psychiatric hospitalization in the last 12 months * significant cognitive impairment determined by inability to comprehend screening assessment * psychiatric problems and/or high suicide risk warranting immediate intervention * neurobiological disorders, Meniere's disease * Temporomandibular disorders that affect tinnitus, per self-report * history of major head trauma with loss of consciousness for 20 minutes or more as determined by the History of Head Injuries questionnaire * history of seizures * conditions that would prevent completion of fMRI scan (any type of electronic, mechanical, or magnetic implant, coil, filter, or stent, any type of surgical clip or staple, shunt, any type of metal object, hearing aid, spinal fusion, halo vest, IV access port, eyelid spring, artificial eye, artificial heart valve, biostimulator, severe hyperacusis) * active conductive pathology/hearing loss as determined by audiometric assessment. * Those with tinnitus (T&P; TO) will be excluded if their tinnitus is intermittent, objective, or pulsatile, or present for less than 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Resting-State Functional MRI30 minutes of acquired dataWe will acquire BOLD fMRI images in an unstimulated state using an extended time-series (300 whole-brain volumes over \ 30 min) and assess for activation within the Auditory Vigilance Network. These data are a main outcome. Data were be processed on an ongoing basis to ensure integrity, and includes controlling for white matter, cerebral spinal fluid, and movement. BOLD levels were transformed to Z-scores, a statistical measure that conveys how many standard deviations the data points are away from the dataset. A Z-score of 0 represents the population mean. For each of the regions reported in the Auditory Vigilance Network, each positive point represents one standard deviation above the population mean. These positive Z-scores represent more brain activation within these regions.

Countries

United States

Participant flow

Participants by arm

ArmCount
Tinnitus and PTSD (T+P)
Active duty service members and/or veterans with PTSD and tinnitus.
16
Tinnitus Only (TO)
Active duty service members and/or veterans with only tinnitus/no PTSD.
25
PTSD Only (PO)
Active duty service members and/or veterans with only PTSD/no tinnitus.
3
Healthy Controls
Active duty service members and/or veterans with no PTSD and no tinnitus.
20
Total64

Baseline characteristics

CharacteristicTotalHealthy ControlsPTSD Only (PO)Tinnitus Only (TO)Tinnitus and PTSD (T+P)
Age, Continuous48.89 years
STANDARD_DEVIATION 15.17
45.37 years
STANDARD_DEVIATION 16
47.69 years
STANDARD_DEVIATION 14.87
49.39 years
STANDARD_DEVIATION 15.5
48.98 years
STANDARD_DEVIATION 15.28
Ethnicity (NIH/OMB)
Hispanic or Latino
14 Participants3 Participants1 Participants7 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
49 Participants17 Participants1 Participants18 Participants13 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
9 Participants5 Participants0 Participants2 Participants2 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants1 Participants2 Participants2 Participants0 Participants
Race (NIH/OMB)
White
50 Participants14 Participants1 Participants21 Participants14 Participants
Region of Enrollment
United States
64 participants20 participants3 participants25 participants16 participants
Sex: Female, Male
Female
19 Participants7 Participants2 Participants8 Participants2 Participants
Sex: Female, Male
Male
45 Participants13 Participants1 Participants17 Participants14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 250 / 30 / 24
other
Total, other adverse events
4 / 121 / 252 / 30 / 24
serious
Total, serious adverse events
0 / 120 / 250 / 30 / 24

Outcome results

Primary

Resting-State Functional MRI

We will acquire BOLD fMRI images in an unstimulated state using an extended time-series (300 whole-brain volumes over \ 30 min) and assess for activation within the Auditory Vigilance Network. These data are a main outcome. Data were be processed on an ongoing basis to ensure integrity, and includes controlling for white matter, cerebral spinal fluid, and movement. BOLD levels were transformed to Z-scores, a statistical measure that conveys how many standard deviations the data points are away from the dataset. A Z-score of 0 represents the population mean. For each of the regions reported in the Auditory Vigilance Network, each positive point represents one standard deviation above the population mean. These positive Z-scores represent more brain activation within these regions.

Time frame: 30 minutes of acquired data

ArmMeasureGroupValue (MEAN)Dispersion
Tinnitus and PTSD (T+P)Resting-State Functional MRIRight Precuneus0.55 Z-ScoreStandard Deviation 0.33
Tinnitus and PTSD (T+P)Resting-State Functional MRILeft Cingulate Gyrus1.54 Z-ScoreStandard Deviation 0.47
Tinnitus and PTSD (T+P)Resting-State Functional MRIRight Supramarginal Gyrus0.53 Z-ScoreStandard Deviation 0.4
Tinnitus and PTSD (T+P)Resting-State Functional MRILeft Cerebellum0.46 Z-ScoreStandard Deviation 0.18
Tinnitus and PTSD (T+P)Resting-State Functional MRILeft Claustrum0.66 Z-ScoreStandard Deviation 0.2
Tinnitus and PTSD (T+P)Resting-State Functional MRIRight Lentiform Nucleus1.03 Z-ScoreStandard Deviation 0.17
Tinnitus and PTSD (T+P)Resting-State Functional MRILeft Superior Temporal Gyrus1.80 Z-ScoreStandard Deviation 0.49
Tinnitus and PTSD (T+P)Resting-State Functional MRIRight Insula2.32 Z-ScoreStandard Deviation 0.32
Tinnitus and PTSD (T+P)Resting-State Functional MRILeft Medial Frontal Gyrus1.32 Z-ScoreStandard Deviation 0.33
Tinnitus and PTSD (T+P)Resting-State Functional MRIRight Middle Frontal Gyrus0.39 Z-ScoreStandard Deviation 0.44
Tinnitus and PTSD (T+P)Resting-State Functional MRILeft Insula0.24 Z-ScoreStandard Deviation 0.17
Tinnitus Only (TO)Resting-State Functional MRIRight Middle Frontal Gyrus0.55 Z-ScoreStandard Deviation 0.32
Tinnitus Only (TO)Resting-State Functional MRILeft Insula0.43 Z-ScoreStandard Deviation 0.24
Tinnitus Only (TO)Resting-State Functional MRILeft Claustrum0.73 Z-ScoreStandard Deviation 0.17
Tinnitus Only (TO)Resting-State Functional MRIRight Supramarginal Gyrus0.98 Z-ScoreStandard Deviation 0.52
Tinnitus Only (TO)Resting-State Functional MRILeft Superior Temporal Gyrus1.67 Z-ScoreStandard Deviation 0.44
Tinnitus Only (TO)Resting-State Functional MRIRight Insula2.82 Z-ScoreStandard Deviation 0.59
Tinnitus Only (TO)Resting-State Functional MRILeft Cingulate Gyrus1.60 Z-ScoreStandard Deviation 0.49
Tinnitus Only (TO)Resting-State Functional MRILeft Medial Frontal Gyrus0.85 Z-ScoreStandard Deviation 0.29
Tinnitus Only (TO)Resting-State Functional MRIRight Lentiform Nucleus1.07 Z-ScoreStandard Deviation 0.19
Tinnitus Only (TO)Resting-State Functional MRILeft Cerebellum0.36 Z-ScoreStandard Deviation 0.2
Tinnitus Only (TO)Resting-State Functional MRIRight Precuneus0.35 Z-ScoreStandard Deviation 0.24
PTSD Only (PO)Resting-State Functional MRILeft Medial Frontal Gyrus0.64 Z-ScoreStandard Deviation 0.08
PTSD Only (PO)Resting-State Functional MRIRight Precuneus0.29 Z-ScoreStandard Deviation 0.22
PTSD Only (PO)Resting-State Functional MRILeft Cerebellum0.47 Z-ScoreStandard Deviation 0.27
PTSD Only (PO)Resting-State Functional MRILeft Superior Temporal Gyrus1.68 Z-ScoreStandard Deviation 0.45
PTSD Only (PO)Resting-State Functional MRILeft Cingulate Gyrus1.49 Z-ScoreStandard Deviation 0.44
PTSD Only (PO)Resting-State Functional MRIRight Lentiform Nucleus0.97 Z-ScoreStandard Deviation 0.02
PTSD Only (PO)Resting-State Functional MRIRight Middle Frontal Gyrus0.37 Z-ScoreStandard Deviation 0.55
PTSD Only (PO)Resting-State Functional MRILeft Claustrum0.84 Z-ScoreStandard Deviation 0.15
PTSD Only (PO)Resting-State Functional MRIRight Supramarginal Gyrus1.16 Z-ScoreStandard Deviation 0.97
PTSD Only (PO)Resting-State Functional MRILeft Insula0.29 Z-ScoreStandard Deviation 0.11
PTSD Only (PO)Resting-State Functional MRIRight Insula0.64 Z-ScoreStandard Deviation 0.48
Healthy ControlsResting-State Functional MRIRight Middle Frontal Gyrus0.84 Z-ScoreStandard Deviation 0.29
Healthy ControlsResting-State Functional MRIRight Insula2.86 Z-ScoreStandard Deviation 0.79
Healthy ControlsResting-State Functional MRILeft Insula0.40 Z-ScoreStandard Deviation 0.17
Healthy ControlsResting-State Functional MRIRight Lentiform Nucleus1.22 Z-ScoreStandard Deviation 0.23
Healthy ControlsResting-State Functional MRILeft Cingulate Gyrus1.99 Z-ScoreStandard Deviation 0.38
Healthy ControlsResting-State Functional MRILeft Superior Temporal Gyrus1.95 Z-ScoreStandard Deviation 0.38
Healthy ControlsResting-State Functional MRILeft Medial Frontal Gyrus0.96 Z-ScoreStandard Deviation 0.33
Healthy ControlsResting-State Functional MRILeft Cerebellum0.54 Z-ScoreStandard Deviation 0.28
Healthy ControlsResting-State Functional MRIRight Precuneus0.59 Z-ScoreStandard Deviation 0.28
Healthy ControlsResting-State Functional MRIRight Supramarginal Gyrus0.95 Z-ScoreStandard Deviation 0.49
Healthy ControlsResting-State Functional MRILeft Claustrum0.82 Z-ScoreStandard Deviation 0.26
p-value: 0.01t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026